EBMT randomized study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC)

被引：0
|
作者：
Leyvraz, Serge
Pampallona, Sandro
Martinelli, Giovanni
Ferdinand, Ploner
Aversa, Savina
Rosti, Giovanni
Brunsvig, Paal
Montes, Ana
Lange, Andrzej
Yilmaz, Ugur
机构：
[1] Univ Lausanne Hosp, Ctr Pluridisciplinaire Oncol, Lausanne, Switzerland
[2] Inst Europeo Oncol, Milan, Italy
[3] Univ Hosp Graz, Graz, Austria
[4] Azienda Univ Hosp, Padua, Italy
[5] Osped Civile, Ravenna, Italy
[6] Norwegian Radium Hosp, Oslo, Norway
[7] Inst Catala Oncol, Barcelona, Spain
[8] Kdulski Hosp, Wroclaw, Poland
[9] Dokuz Eylul Univ, Tip Fak, Izmir, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [1] Randomized phase III study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC): Results of the EBMT Random-ICE trial.
    Leyvraz, S.
    Pampallona, S.
    Martinelli, G.
    Ploner, F.
    Aversa, S.
    Rosti, G.
    Brunsvig, P.
    Montes, A.
    Yilmaz, U.
    Perey, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 380S - 380S
  • [2] High-dose sequential chemotherapy supported by peripheral blood progenitor cells for the treatment of small cell lung cancer: Results of the EBMT RandomICE trial
    Leyvraz, S.
    Pampallona, S.
    Martinelli, G.
    Ploner, F.
    Aversa, S.
    Brunsvig, P.
    Montes, A.
    Lange, A.
    Yilmaz, U.
    Rosti, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S16 - S17
  • [3] Final results of the EBMT study of sequential high-dose ICE with circulating progenitor cells (CPC) in small cell lung cancer (SCLC).
    Perey, L
    Rosti, G
    Lange, A
    Bosquée, L
    Pasini, F
    Humblet, Y
    Hamdan, O
    Pampallona, S
    Leyvraz, S
    BONE MARROW TRANSPLANTATION, 1998, 22 : S111 - S114
  • [4] Sequential high-dose chemotherapy for small cell lung cancer: An EBMT phase II study
    Leyvraz, S
    Perey, L
    Rosti, G
    Lange, A
    Pampallona, S
    Pasini, F
    Bosquee, L
    Humblet, Y
    Marangolo, M
    ANNALS OF ONCOLOGY, 1998, 9 : 84 - 84
  • [5] High-dose sequential chemotherapy (HDSC) with peripheral blood progenitor cells (PBPC) support for high-risk breast cancer (BC)
    Sabbatini, R.
    Da Prada, G. A.
    Frassineti, G. L.
    Aietta, M.
    Pedrazzoli, P.
    Maur, M.
    Zambelli, A.
    Giovannini, N.
    Siena, S.
    Ponchio, L.
    Conte, P. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] High dose chemotherapy (HDC) supported by peripheral blood progenitor cells (PBPC) in patients with advanced ovarian cancer
    De Rosa, L
    Pescarollo, A
    Blandino, F
    Zoli, V
    Pescador, L
    Pandolfi, A
    Amodeo, R
    De Laurenzi, A
    ANNALS OF ONCOLOGY, 1998, 9 : 71 - 72
  • [7] Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.
    Stein, DT
    Mackall, CL
    Bare, CV
    Brown, MR
    Carter, CS
    Casey, N
    Yu, MY
    Fleisher, TA
    Leitman, SF
    Shearer, GM
    Wexler, L
    Gress, RE
    PEDIATRIC RESEARCH, 1996, 39 (04) : 962 - 962
  • [8] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Huober, J
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 661 - 661
  • [9] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Fruhauf, S
    Bastert, G
    BREAST, 1997, 6 (05): : 321 - 321
  • [10] Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
    Wasserfallen, JB
    Rollier, P
    Leyvraz, S
    Perey, L
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 243 - 244
12345